Fibroblast growth factor receptor 4 (FGFR4) and fibroblast growth factor 19 (FGF19) autocrine enhance breast cancer cells survival-Reference-Cited by-同舟云学术

Fibroblast growth factor receptor 4 (FGFR4) and fibroblast growth factor 19 (FGF19) autocrine enhance breast cancer cells survival

Published:2016-05-12 Issue:36 Volume:7 Page:57633-57650
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Tiong Kai Hung¹²³,Tan Boon Shing¹⁴,Choo Heng Lungh¹⁵,Chung Felicia Fei-Lei⁵,Hii Ling-Wei¹⁵,Tan Si Hoey¹⁵,Khor Nelson Tze Woei⁶,Wong Shew Fung⁷,See Sze-Jia⁵,Tan Yuen-Fen¹⁵,Rosli Rozita⁸,Cheong Soon-Keng⁹,Leong Chee-Onn⁵¹⁰

Affiliation:

1. School of Postgraduate Studies, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia

2. Oral Cancer Research and Co-ordinating Center (OCRCC), Faculty of Dentistry, University of Malaya, Kuala Lumpur, Malaysia

3. Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia

4. Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan

5. Center for Cancer and Stem Cell Research, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia

6. School of Medicine, Faculty of Medical and Health Sciences, The University of Auckland, New Zealand

7. School of Medicine, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia

8. UPM-MAKNA Cancer Research Laboratory, Institute of Bioscience, Universiti Putra Malaysia, UPM Serdang, Selangor, Malaysia

9. Faculty of Medicine and Health Sciences, University Tunku Abdul Rahman, Bandar Sungai Long, Selangor, Malaysia

10. School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FGFR4-driven plasticity in breast cancer progression and resistance to therapy;British Journal of Cancer;2024-04-17

2. Estrogen regulation and functional role of FGFR4 in estrogen receptor positive breast cancer;2024-03-20

3. Discovery of 6-Formylpyridyl Urea Derivatives as Potent Reversible-Covalent Fibroblast Growth Factor Receptor 4 Inhibitors with Improved Anti-Hepatocellular Carcinoma Activity;Journal of Medicinal Chemistry;2024-02-13

4. Exploring endocrine FGFs - structures, functions and biomedical applications;International Journal of Biochemistry and Molecular Biology;2024

5. FGF19 promotes nasopharyngeal carcinoma progression by inducing angiogenesis via inhibiting TRIM21-mediated ANXA2 ubiquitination;Cellular Oncology;2023-10-02